217 related articles for article (PubMed ID: 37162929)
1. Expansion of Disease Specific Cardiac Macrophages in Immune Checkpoint Inhibitor Myocarditis.
Ma P; Liu J; Qin J; Lai L; Heo GS; Luehmann H; Sultan D; Bredemeyer A; Bajapa G; Feng G; Jimenez J; Parks A; Amrute J; Villanueva A; Liu Y; Lin CY; Mack M; Amancherla K; Moslehi J; Lavine KJ
bioRxiv; 2023 Apr; ():. PubMed ID: 37162929
[TBL] [Abstract][Full Text] [Related]
2. Expansion of Pathogenic Cardiac Macrophages in Immune Checkpoint Inhibitor Myocarditis.
Ma P; Liu J; Qin J; Lai L; Heo GS; Luehmann H; Sultan D; Bredemeyer A; Bajapa G; Feng G; Jimenez J; He R; Parks A; Amrute J; Villanueva A; Liu Y; Lin CY; Mack M; Amancherla K; Moslehi J; Lavine KJ
Circulation; 2024 Jan; 149(1):48-66. PubMed ID: 37746718
[TBL] [Abstract][Full Text] [Related]
3. Identification of Pathogenic Immune Cell Subsets Associated With Checkpoint Inhibitor-Induced Myocarditis.
Zhu H; Galdos FX; Lee D; Waliany S; Huang YV; Ryan J; Dang K; Neal JW; Wakelee HA; Reddy SA; Srinivas S; Lin LL; Witteles RM; Maecker HT; Davis MM; Nguyen PK; Wu SM
Circulation; 2022 Jul; 146(4):316-335. PubMed ID: 35762356
[TBL] [Abstract][Full Text] [Related]
4. T cells specific for α-myosin drive immunotherapy-related myocarditis.
Axelrod ML; Meijers WC; Screever EM; Qin J; Carroll MG; Sun X; Tannous E; Zhang Y; Sugiura A; Taylor BC; Hanna A; Zhang S; Amancherla K; Tai W; Wright JJ; Wei SC; Opalenik SR; Toren AL; Rathmell JC; Ferrell PB; Phillips EJ; Mallal S; Johnson DB; Allison JP; Moslehi JJ; Balko JM
Nature; 2022 Nov; 611(7937):818-826. PubMed ID: 36385524
[TBL] [Abstract][Full Text] [Related]
5. A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor-Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention.
Wei SC; Meijers WC; Axelrod ML; Anang NAS; Screever EM; Wescott EC; Johnson DB; Whitley E; Lehmann L; Courand PY; Mancuso JJ; Himmel LE; Lebrun-Vignes B; Wleklinski MJ; Knollmann BC; Srinivasan J; Li Y; Atolagbe OT; Rao X; Zhao Y; Wang J; Ehrlich LIR; Sharma P; Salem JE; Balko JM; Moslehi JJ; Allison JP
Cancer Discov; 2021 Mar; 11(3):614-625. PubMed ID: 33257470
[TBL] [Abstract][Full Text] [Related]
6. Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade.
Kawada-Horitani E; Kita S; Okita T; Nakamura Y; Nishida H; Honma Y; Fukuda S; Tsugawa-Shimizu Y; Kozawa J; Sakaue T; Kawachi Y; Fujishima Y; Nishizawa H; Azuma M; Maeda N; Shimomura I
Diabetologia; 2022 Jul; 65(7):1185-1197. PubMed ID: 35511238
[TBL] [Abstract][Full Text] [Related]
7. T cells and monocyte-derived myeloid cells mediate immunotherapy-related hepatitis in a mouse model.
Llewellyn HP; Arat S; Gao J; Wen J; Xia S; Kalabat D; Oziolor E; Virgen-Slane R; Affolter T; Ji C
J Hepatol; 2021 Nov; 75(5):1083-1095. PubMed ID: 34242700
[TBL] [Abstract][Full Text] [Related]
8. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.
House IG; Savas P; Lai J; Chen AXY; Oliver AJ; Teo ZL; Todd KL; Henderson MA; Giuffrida L; Petley EV; Sek K; Mardiana S; Gide TN; Quek C; Scolyer RA; Long GV; Wilmott JS; Loi S; Darcy PK; Beavis PA
Clin Cancer Res; 2020 Jan; 26(2):487-504. PubMed ID: 31636098
[TBL] [Abstract][Full Text] [Related]
9.
Boughdad S; Latifyan S; Fenwick C; Bouchaab H; Suffiotti M; Moslehi JJ; Salem JE; Schaefer N; Nicod-Lalonde M; Costes J; Perreau M; Michielin O; Peters S; Prior JO; Obeid M
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34686542
[TBL] [Abstract][Full Text] [Related]
10. Cardiac myosin-specific autoimmune T cells contribute to immune-checkpoint-inhibitor-associated myocarditis.
Won T; Kalinoski HM; Wood MK; Hughes DM; Jaime CM; Delgado P; Talor MV; Lasrado N; Reddy J; Čiháková D
Cell Rep; 2022 Nov; 41(6):111611. PubMed ID: 36351411
[TBL] [Abstract][Full Text] [Related]
11. CD40 is an immune checkpoint regulator that potentiates myocardial inflammation through activation and expansion of CCR2
Jimenez J; Amrute J; Ma P; Wang X; Dai R; Lavine KJ
bioRxiv; 2024 Mar; ():. PubMed ID: 38559055
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of low-intensity pulsed ultrasound on immune checkpoint inhibitor-related myocarditis via fine-tuning CD4
Fu S; Guo Z; Xu X; Li Y; Choi S; Zhao P; Shen W; Gao F; Wang C; Chen S; Li Y; Tian J; Sun P
Cancer Immunol Immunother; 2024 Jan; 73(1):15. PubMed ID: 38236243
[TBL] [Abstract][Full Text] [Related]
13. Myocarditis in Cynomolgus Monkeys Following Treatment with Immune Checkpoint Inhibitors.
Ji C; Roy MD; Golas J; Vitsky A; Ram S; Kumpf SW; Martin M; Barletta F; Meier WA; Hooper AT; Sapra P; Khan NK; Finkelstein M; Guffroy M; Buetow BS
Clin Cancer Res; 2019 Aug; 25(15):4735-4748. PubMed ID: 31085720
[TBL] [Abstract][Full Text] [Related]
14. Single-cell RNA sequencing reveals the altered innate immunity in immune checkpoint inhibitor-related myocarditis.
Lou B; Guo M; Zheng T; Liu J; Wang C; Chen T; Chen F; Fan X; Gao S; Liang X; Qiang H; Li L; Zhou B; Yuan Z; She J
Immunology; 2024 Jun; 172(2):235-251. PubMed ID: 38425094
[TBL] [Abstract][Full Text] [Related]
15. Single-cell transcriptomics identifies pathogenic T-helper 17.1 cells and pro-inflammatory monocytes in immune checkpoint inhibitor-related pneumonitis.
Franken A; Van Mol P; Vanmassenhove S; Donders E; Schepers R; Van Brussel T; Dooms C; Yserbyt J; De Crem N; Testelmans D; De Wever W; Nackaerts K; Vansteenkiste J; Vos R; Humblet-Baron S; Lambrechts D; Wauters E
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36171010
[TBL] [Abstract][Full Text] [Related]
16. Borrelia burgdorferi stimulation of chemokine secretion by cells of monocyte lineage in patients with Lyme arthritis.
Shin JJ; Strle K; Glickstein LJ; Luster AD; Steere AC
Arthritis Res Ther; 2010; 12(5):R168. PubMed ID: 20828409
[TBL] [Abstract][Full Text] [Related]
17. High baseline tumor burden-associated macrophages promote an immunosuppressive microenvironment and reduce the efficacy of immune checkpoint inhibitors through the IGFBP2-STAT3-PD-L1 pathway.
Wen Z; Sun H; Zhang Z; Zheng Y; Zheng S; Bin J; Liao Y; Shi M; Zhou R; Liao W
Cancer Commun (Lond); 2023 May; 43(5):562-581. PubMed ID: 37031362
[TBL] [Abstract][Full Text] [Related]
18. Heart-Specific Immune Responses in an Animal Model of Autoimmune-Related Myocarditis Mitigated by an Immunoproteasome Inhibitor and Genetic Ablation.
Bockstahler M; Fischer A; Goetzke CC; Neumaier HL; Sauter M; Kespohl M; Müller AM; Meckes C; Salbach C; Schenk M; Heuser A; Landmesser U; Weiner J; Meder B; Lehmann L; Kratzer A; Klingel K; Katus HA; Kaya Z; Beling A
Circulation; 2020 Jun; 141(23):1885-1902. PubMed ID: 32160764
[TBL] [Abstract][Full Text] [Related]
19. Hormonal therapies up-regulate MANF and overcome female susceptibility to immune checkpoint inhibitor myocarditis.
Zhang Y; Sun C; Li Y; Qin J; Amancherla K; Jing Y; Hu Q; Liang K; Zhang Z; Ye Y; Huang LA; Nguyen TK; Egranov SD; Zhao Z; Wu A; Xi Y; Yao J; Hung MC; Calin GA; Cheng J; Lim B; Lehmann LH; Salem JE; Johnson DB; Curran MA; Yu D; Han L; Darabi R; Yang L; Moslehi JJ; Lin C
Sci Transl Med; 2022 Nov; 14(669):eabo1981. PubMed ID: 36322628
[TBL] [Abstract][Full Text] [Related]
20. Toxicity-specific peripheral blood T and B cell dynamics in anti-PD-1 and combined immune checkpoint inhibition.
van Eijs MJM; Verheijden RJ; van der Wees SA; Nierkens S; van Lindert ASR; Suijkerbuijk KPM; van Wijk F;
Cancer Immunol Immunother; 2023 Dec; 72(12):4049-4064. PubMed ID: 37794264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
